News

Entering the Swiss market with a rare disease product presents unique opportunities, as the country’s authorities offer strong support in...

The Swiss regulatory and market access landscape offers multiple pathways for introducing new medicines to the Swiss market, particularly...

The Swiss pharmaceutical industry – a pivotal component of Switzerland’s economy generating 5% of the nation’s GDP and accounting for...

Foreign biotech and pharmaceutical companies wishing to enter the Swiss market must navigate a comprehensive regulatory framework,...

The clustering of life sciences companies in Switzerland started over 60 years ago when Switzerland managed to lure many foreign...

In this new series, we break down the challenges of entering the Swiss healthcare market to enable a deeper and clearer understanding of...